ENT Liu Knowledge Base Head & neck tumours · physician reviewed
Laryngeal Cancer · Treatment

What are the treatment options for laryngeal cancer?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: Laryngeal Cancer Answer length: short, citable
Quick answer

Treatment is stage- and site-specific, and usually combines carcinoma in situ and T1–T2 glottic cancer: definitive radiotherapy or transoral laser / partial laryngectomy — both aim to preserve voice, selected supraglottic T1–T2: supraglottic partial laryngectomy or radiotherapy with neck management and locally advanced resectable disease: total laryngectomy with neck dissection followed by risk-adapted radiotherapy or chemoradiotherapy. Early-stage disease is generally treated with one modality (surgery or radiotherapy), while locally advanced disease needs combined modality treatment planned by a multidisciplinary team.

In detail

The decision is made by a tumour board including head and neck surgery, radiation oncology, medical oncology, radiology, pathology, dentistry, nutrition and speech/swallow rehabilitation. Functional outcome — speech, swallowing, breathing and appearance — is considered alongside cancer control.

Ask your team explicitly whether the goal is curative, organ-preserving or palliative, and whether a clinical trial is available. NCCN and NCI patient guidelines are a useful checklist for these questions.

  • Carcinoma in situ and T1–T2 glottic cancer: definitive radiotherapy or transoral laser / partial laryngectomy — both aim to preserve voice
  • Selected supraglottic T1–T2: supraglottic partial laryngectomy or radiotherapy with neck management
  • Locally advanced resectable disease: total laryngectomy with neck dissection followed by risk-adapted radiotherapy or chemoradiotherapy
  • Larynx-preservation protocols: concurrent cisplatin-based chemoradiotherapy, or induction chemotherapy (TPF) followed by radiotherapy in responders
  • Postoperative concurrent chemoradiotherapy for positive margins or extranodal extension
  • Recurrent/metastatic disease: PD-1 immunotherapy, chemotherapy, targeted therapy or clinical trials; best supportive care when appropriate

What this means in practice: this answer is part of the “Treatment” section of the Laryngeal Cancer topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about laryngeal cancer

See all 14 questions in this topic →

Sources for this answer

  1. NCCN Guidelines for Patients: Head and Neck Cancers National Comprehensive Cancer Network · 2025
  2. Head and Neck Cancers (patient information) US National Cancer Institute · 2025
  3. Global Cancer Observatory (GLOBOCAN 2022) International Agency for Research on Cancer / WHO · 2022 · Source of worldwide and country-level incidence and mortality estimates.
  4. Global Cancer Facts & Figures, 5th Edition (GLOBOCAN 2022 tables) American Cancer Society · 2024
  5. Nivolumab Risk Management Plan — epidemiological characteristics of SCCHN (GLOBOCAN 2022 summary) European Medicines Agency · 2025 · Reports the combined 947,211 head and neck cancer cases in 2022 and regional ASRs.
  6. Global burden and international trends in laryngeal cancer incidence (GLOBOCAN 2022 and CI5-XII) Japanese Journal of Clinical Oncology / registry-based review · 2025

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

← Previous questionHow is laryngeal cancer diagnosed and staged? Next question →What is the prognosis for laryngeal cancer?

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.